Day: February 13, 2023

Sotera Health Confirms Preliminary 2022 Full-Year Guidance in Conjunction with Incremental Debt Financing

Written by Customer Service on February 13, 2023. Posted in Earnings Releases And Operating Results.

CLEVELAND, Feb. 13, 2023 (GLOBE NEWSWIRE) — Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its intention to enter into a new senior secured Term Loan B facility in an aggregate principal amount of $425 million, which is expected to fund and close during the first quarter. The Company plans to use proceeds of this debt financing, along with cash on hand, to: a) fund a previously announced planned $408 million ethylene oxide litigation settlement in Cook County, IL, b) pay down existing borrowings under the Company’s revolving credit facility, and c) further enhance liquidity. Preliminary Financial Results for the Year Ended December 31, 2022 Our...

Monarch Reports Its Second Quarter Results and Final Closing of the Private Placement

Written by Customer Service on February 13, 2023. Posted in Earnings Releases And Operating Results.

Not for distribution to U.S. news wire services or dissemination in the United States MONTRÉAL, Feb. 13, 2023 (GLOBE NEWSWIRE) — MONARCH MINING CORPORATION (“Monarch” or the “Corporation”) (TSX: GBAR) (OTCQB: GBARF) reported its results today for the second quarter ended December 31, 2022. Amounts are in Canadian dollars unless otherwise indicated. Summary of financial results(In dollars except per-share data) Three months endedDecember 31, 2022 Six months endedDecember 31, 2022 2022 2021 2022 2021 Revenues 544,390 – 2,549,995 – Cost of sales (874,258 ) – (17,546,397 ) – Loss from mine operations (329,868 ) – (14,996,402 ) – Administration expenses (1,299,168 ) (2,374,268 ) (2,227,953 ) (4,289,297 )Care and maintenance expenses (873,851 ) – (873,851 ) – Exploration expenses (66,555 ) (714,471 ) (207,868 ) (2,444,166 )Operating...

B2Gold Corp. Announces Acquisition of Sabina Gold & Silver Corp.

Written by Customer Service on February 13, 2023. Posted in Mergers And Acquisitions.

Black River Gold Project Black River Gold ProjectVANCOUVER, British Columbia, Feb. 13, 2023 (GLOBE NEWSWIRE) — B2Gold Corp. (TSX: BTO, NYSE MKT: BTG, NSX: B2G) (“B2Gold”) and Sabina Gold & Silver Corp (“Sabina”) are pleased to announce that the parties have entered into a definitive agreement (the “Agreement”) pursuant to which B2Gold has agreed to acquire all of the issued and outstanding shares of Sabina (the “Transaction”). The Transaction will result in B2Gold acquiring Sabina’s 100% owned Back River Gold District located in Nunavut, Canada. The Back River Gold District consists of five mineral claims blocks along an 80 kilometre (“km”) belt. The most advanced project in the district, Goose, is fully permitted, construction ready, and has been de-risked with significant infrastructure currently in place. B2Gold has...

Movella Announces Trading of Common Stock on Nasdaq Global Market

Written by Customer Service on February 13, 2023. Posted in Mergers And Acquisitions.

Movella Announces Trading on the Nasdaq Global Stock Market on Feb. 13, 2023 Movella Announces Trading on the Nasdaq Global Stock Market on Feb. 13, 2023HENDERSON, Nev., Feb. 13, 2023 (GLOBE NEWSWIRE) — Movella Holdings Inc. (NASDAQ:MVLA) (“Movella”), a global leader in the digitization of movement, will begin trading its common stock and warrants on the Nasdaq Global Market under the ticker symbols “MVLA” and “MVLAW”, respectively, today, following its successful merger with Pathfinder Acquisition Corp. (“Pathfinder”), a special purpose acquisition corporation, on Feb. 10, 2023. Movella’s advanced inertial sensor technology, together with its software and analytics, represent a highly differentiated full-stack solution for the digitization of movement for customers in entertainment, health & sports, and automation...

Aprea Therapeutics Announces One-for-Twenty Reverse Stock Split

Written by Customer Service on February 13, 2023. Posted in Public Companies.

DOYLESTOWN, Pa., Feb. 13, 2023 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (the “Company”), a biopharmaceutical company focused on developing novel synthetic lethality-based cancer therapeutics targeting DNA damage response (DDR) pathways, today announced a one-for-twenty reverse stock split of the Company’s common stock, par value $0.001, which became effective at 5:00 pm Eastern Time on February 10, 2023. The Company’s common stock will trade on the Nasdaq Global Select Market on a split-adjusted basis beginning on February 13, 2023, under the Company’s existing trading symbol “APRE”. The Company is implementing the reverse stock split as planned to increase the per share price of its common stock to regain compliance with the listing requirements of the Nasdaq Global Select Market. The reverse stock split will...

Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer

Written by Customer Service on February 13, 2023. Posted in Public Companies.

ALACHUA, Fla. and TAMPA, Fla., Feb. 13, 2023 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Jens Schroeder Kemp to the newly created role of Chief Marketing Officer. Kemp brings more than 20 years of strategic marketing, sales, and business development experience in high-growing medical technology. As a member of the Axogen executive leadership team, Kemp will report directly to Karen Zaderej, Chairman, CEO and President, and will oversee the development and execution of the company’s marketing strategies. “I am thrilled to welcome Jens to Axogen. His extensive strategic marketing experience and track record of growth is an ideal addition to our team,” commented Ms. Zaderej. “We look forward...

First Wave BioPharma Chairman and CEO Issues Letter to Stockholders

Written by Customer Service on February 13, 2023. Posted in Public Companies.

BOCA RATON, Fla., Feb. 13, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that James Sapirstein, Chairman, President and CEO of First Wave BioPharma, has issued a Letter to Stockholders providing an update on the Company’s clinical programs and recent events. The full text of the letter follows. A MESSAGE FROM OUR CHAIRMAN AND CHIEF EXECUTIVE OFFICER To my fellow stockholders, We look forward to 2023 after a challenging 2022 when small biotechnology companies endured one of their worst years on record. First Wave BioPharma was not immune to this unfortunate trend, but we weathered the storm. We look forward...

HOOKIPA Achieves $10 Million Milestone Payment in Development of Immunotherapy for KRAS-Mutated Cancers

Written by Customer Service on February 13, 2023. Posted in Public Companies.

NEW YORK and VIENNA, Austria, Feb. 13, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapies based on its proprietary arenavirus platform, today announced that it has achieved a $10 million non-dilutive milestone payment under its collaboration agreement with Roche to develop HB-700, a novel arenaviral immunotherapy for KRAS-mutated cancers. The success-based milestone payment reflects the start of the HB-700 manufacturing process to support a Phase 1 clinical trial. HOOKIPA plans to submit an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration in the first half of 2024. “We’re really pleased to start the year strongly by achieving this milestone in our collaboration with Roche to develop HB-700 for KRAS-mutated cancers,” said Joern...

First National Corporation Announces 7% Increase in Cash Dividend

Written by Customer Service on February 13, 2023. Posted in Public Companies.

STRASBURG, Va., Feb. 13, 2023 (GLOBE NEWSWIRE) — The Board of Directors of First National Corporation (Nasdaq: FXNC) declared a quarterly cash dividend of $0.15 per share on February 8, 2023. This was a 7% increase compared to the quarterly dividend paid on December 16, 2022. The dividend is payable on March 10, 2023, to shareholders of record as of February 24, 2023. ABOUT FIRST NATIONAL CORPORATION First National Corporation (NASDAQ: FXNC) is the parent company and bank holding company of First Bank, a community bank that first opened for business in 1907 in Strasburg, Virginia. The Bank offers loan and deposit products and services through its website, fbvirginia.com, its mobile banking platform, a network of ATMs located throughout its market area, a loan production office, two customer service centers in retirement communities,...

PowerTap Provides Update on Gen3 Onsite Blue Hydrogen Technology

Written by Customer Service on February 13, 2023. Posted in Public Companies.

VANCOUVER, British Columbia and ALISO VIEJO, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) — PowerTap Hydrogen Capital Corp. (NEO: MOVE) (OTC: MOTNF) (“PowerTap” or the “Company” or “MOVE”) provides an update on the activities of PowerTap and its subsidiary, PowerTap Hydrogen Fueling Corp. Further to the Company’s press release on November 23, 2022, PowerTap Hydrogen Fueling Corp., in conjunction with T2M Global, PowerTap’s technology partner, have further progressed the engineering and supply chain validation of the PowerTap Gen3 Modular Hydrogen Production and Dispensing Unit (MHPDU) in PowerTap’s plan to establish light-duty and heavy-duty fuel cell electric vehicle (FCEV) hydrogen (H2) refueling stations by 2024. As part of T2M Global’s progress on supply chain and technology validation of PowerTap’s Gen3 unit, T2M has...

Day: February 13, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice